Real-world effectiveness, its predictors and onset of action of cholinesterase inhibitors and memantine in dementia: retrospective health record study

Nemanja Vaci, Ivan Koychev, Chi‐Hun Kim, Andrey Kormilitzin, Qiang Liu, Christopher G. Lucas, Azad Dehghan, Goran Nenadić, Alejo Nevado‐HolgadoThe British Journal of Psychiatry 2020 · DOI

Abstract

This study presents one of the largest real-world examination of the efficacy of acetylcholinesterase inhibitors and memantine for symptomatic treatment of dementia. We found evidence that 68% of individuals respond to treatment with a period of cognitive stabilisation before continuing their decline at the pre-treatment rate.
BibTeX
@article{vaci2020real,
  author = {Nemanja Vaci and Ivan Koychev and Chi‐Hun Kim and Andrey Kormilitzin and Qiang Liu and Christopher G. Lucas and Azad Dehghan and Goran Nenadić and Alejo Nevado‐Holgado},
  title = {{Real-world effectiveness, its predictors and onset of action of cholinesterase inhibitors and memantine in dementia: retrospective health record study}},
  journal = {The British Journal of Psychiatry},
  year = {2020},
  doi = {10.1192/bjp.2020.136},
}

Loading related content...

Figure